SNSW

Zhitong · Oct 13, 2025 at 06:32 AM

SNSW issued a profit warning, expecting a year-on-year increase of 100.53% in net profit attributable to the parent company for the first three quarters, reaching 145.10 million

Zhitong · Aug 22, 2025 at 04:24 AM

SNSW: Shareholders Chuanfa Investment, Lu Changliang, and Wang Xiaoli plan to collectively reduce their holdings by no more than 3.43%

Zhitong · Aug 14, 2025 at 04:55 AM

SNSW released its semi-annual performance report, with a net profit attributable to the parent company of 88.96 million yuan, a year-on-year increase of 308.29%

Zhitong · Jul 22, 2025 at 04:04 AM

SNSW: Acetate Ganirelix Injection has obtained a drug registration certificate

Zhitong · Jul 13, 2025 at 06:27 PM

Hong Kong Stock Concept Tracking | New Commercial Insurance Innovative Drug Directory Added! 2025 Medical Insurance Directory Adjustment Starts, Will Innovative Drugs Welcome a Historic Turning Point? (Including Concept Stocks)

Zhitong · Jul 7, 2025 at 08:37 PM

The CRO concept surged sharply at the beginning of the session, with ChemPartner rising over 11%, HUIYU PHARMACEUTICAL, SNSW, CTI, and PR all rising over 5%